The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Twelve-Month Outcomes After Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients: A Single-Group Trial
Abstract
Background: Organs from hepatitis C virus (HCV)-infected deceased donors are often discarded. Preliminary data from 2 small trials, including THINKER-1 (Transplanting Hepatitis C kidneys Into Negative KidnEy Recipients), suggested that HCV-infected kidneys could be safely transplanted into HCV-negative patients. However, intermediate-term data on quality of life and renal function are needed to counsel patients about risk. Objective: To describe 12-month HCV treatment outcomes, estimated glomerular filtration rate (eGFR), and quality of life for the 10 kidney recipients in THINKER-1 and 6-month data on 10 additional recipients. Design: Open-label, nonrandomized trial. (ClinicalTrials.gov: NCT02743897). Setting: Single center. Participants: 20 HCV-negative transplant candidates. Intervention: Participants underwent transplant with kidneys infected with genotype 1 HCV and received elbasvir-grazoprevir on posttransplant day 3. Measurements: The primary outcome was HCV cure. Exploratory outcomes included 1) RAND-36 Physical Component Summary (PCS) and Mental Component Summary (MCS) quality-of-life scores at enrollment and after transplant, and 2) posttransplant renal function, which was compared in a 1:5 matched sample with recipients of HCV-negative kidneys. Results: The mean age of THINKER participants was 56.3 years (SD, 6.7), 70% were male, and 40% were black. All 20 participants achieved HCV cure. Hepatic and renal complications were transient or were successfully managed. Mean PCS and MCS quality-of-life scores decreased at 4 weeks; PCS scores then increased above pretransplant values, whereas MCS scores returned to baseline values. Estimated GFRs were similar between THINKER participants and matched recipients of HCV-negative kidneys at 6 months (median, 67.5 vs. 66.2 mL/min/1.73 m2; 95% CI for between-group difference, -4.2 to 7.5 mL/min/1.73 m2) and 12 months (median, 72.8 vs. 67.2 mL/min/1.73 m2; CI for between-group difference, -7.2 to 9.8 mL/min/1.73 m2). Limitation: Small trial. Conclusion: Twenty HCV-negative recipients of HCV-infected kidneys experienced HCV cure, good quality of life, and excellent renal function. Kidneys from HCV-infected donors may be a valuable transplant resource. Primary Funding Source: Merck.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021
Cited by
Ghany, M. G., Morgan, T. R., & Panel, A. H. C. G. (2020) · Hepatology · doi:10.1002/hep.31060 · Cited by 955
EASL Clinical Practice Guidelines on liver transplantation
Samuel, D., De Martin, E., Berg, T., Berenguer, M., Burra, P., Fondevila, C., Heimbach, J. K., Pageaux, G.-P., Sanchez-Fueyo, A., & Toso, C. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.07.032 · Cited by 263
Bixler, D., Annambholta, P., Abara, W. E., Collier, M. G., Jones, J., Mixson-Hayden, T., Basavaraju, S. V., Ramachandran, S., Kamili, S., & Moorman, A. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15352 · Cited by 29
Metadata
- Authors
- Reese, P. P., Abt, P. L., Blumberg, E. A., Van Deerlin, V. M., Bloom, R. D., Potluri, V. S., Levine, M., Porrett, P., Sawinski, D., Nazarian, S. M., Naji, A., Hasz, R., Suplee, L., Trofe-Clark, J., Sicilia, A., McCauley, M., Gentile, C., Smith, J., Niknam, B. A., Bleicher, M., Reddy, K. R., & Goldberg, D. S.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2018-09-04
- Volume
- 169
- Issue
- 5
- Pages
- 273-281
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2886130990
- Cited by
- 226
- References
- 1
- FWCI
- 19.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Twelve-Month Outcomes After Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients: A Single-Group Trial. https://app.cochat.ai/papers/10.7326/m18-0749
- The paper
- Reese, P. P., Abt, P. L., Blumberg, E. A., Van Deerlin, V. M., Bloom, R. D., Potluri, V. S., Levine, M., Porrett, P., Sawinski, D., Nazarian, S. M., Naji, A., Hasz, R., Suplee, L., Trofe-Clark, J., Sicilia, A., McCauley, M., Gentile, C., Smith, J., Niknam, B. A., . . . Goldberg, D. S. (2018). Twelve-Month Outcomes After Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients: A Single-Group Trial. Annals of Internal Medicine. https://doi.org/10.7326/m18-0749
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.